NEW YORK, July 15, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Milacron Holdings Corp. (MCRN) on behalf of Milacron shareholders concerning the proposed merger with Hillenbrand, Inc.
Click here to participate in the action.
Pursuant to the proposed transaction, announced on July 12, 2019 and valued at $2 billion, Milacron shareholders will receive $11.80 in cash and 0.1612 shares of Hillenbrand common stock for every share of Milacron common stock owned. The investigation focuses on whether Milacron and its board of directors violated the federal securities laws and/or breached their fiduciary duties to the Company’s shareholders by failing to conduct a fair process and whether and by how much the proposed transaction undervalues the Company.
If you own Milacron shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at email@example.com, or telephone at (212) 308-1869, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning our investigation of Milacron please go to https://bespc.com/mcrn/. For additional information about Bragar Eagel & Squire, P.C. please go to www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.